Valproate-Induced Pancytopenia and Phenytoin Toxicity in a Young Adult With Intellectual Disability and Mesial Temporal Lobe Sclerosis

References (9)

1. Bowley C, Kerr M. Epilepsy and intellectual disability. J Intellect Disabil Res. 2000;44(Pt 5):529–543. PubMed CrossRef
2. Robertson J, Hatton C, Emerson E, et al. Prevalence of epilepsy among people with intellectual disabilities: a systematic review. Seizure. 2015;29:46–62. PubMed CrossRef
3. Yoshimura Y, Hara K, Akaza M, et al. Effects of antiepileptic monotherapy on hematological and biochemical parameters. Epilepsy & Seizure. 2019;11(1):1–13. CrossRef
4. Goyal SK, Badyal DK. Significant thrombocytopenia with sodium valproate in an adult patient with alcohol dependence. Indian J Psychiatry. 2018;60(2):252–253. PubMed CrossRef
5. Mittal K, Mehta P, Aggarwal HK, et al. Valproate induced thrombocytopenia and renal dysfunction: case report. Eur J Biomed Pharm Sci. 2017;4(1):449–450.
6. Abdulla MC. Multiple adverse events of valproate in a patient with bipolar affective disorder. Ann Indian Psychiatry. 2020;4(1):102–103.
7. Acharya S, Bussel JB. Hematologic toxicity of sodium valproate. J Pediatr Hematol Oncol. 2000;22(1):62–65. PubMed CrossRef
8. Buoli M, Serati M, Botturi A, et al. The risk of thrombocytopenia during valproic acid therapy: a critical summary of available clinical data. Drugs R D. 2018;18(1):1–5. PubMed CrossRef
9. Verrotti A, Scaparrotta A, Grosso S, et al. Anticonvulsant drugs and hematological disease. Neurol Sci. 2014;35(7):983–993. PubMed CrossRef